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Abstract
Linkage to 7q has been the most robust genetic finding in familial autism. A previous scan of
multiplex families with autism spectrum disorders found a linkage signal of genome-wide
significance at D7S530 on 7q32. We searched a candidate imprinted region at this location for
genetic variants in families with positive linkage scores. Using exon resequencing, we identified
three rare potentially pathogenic variants in the TSGA14 gene, which encodes a centrosomal
protein. Two variants were missense mutations (c.664C>G; p.P206A and c.766T>G; p.C240G)
that changed conserved residues in the same protein domain; the third variant (c.192+5G>A)
altered splicing, which resulted in a protein with an internal deletion of 16 residues and a G33D
substitution. These rare TSGA14 variants are enriched in the affected subjects (6/348 patients
versus 2/670 controls, Fisher's exact two tailed p= 0.022). This is the first report of a possible link
of a gene with a centrosomal function with familial autism.
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INTRODUCTION
Autism spectrum disorders (ASD) are a group of hereditary neurodevelopmental conditions
characterized by impaired social interaction and communication, and accompanied by
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repetitive and stereotyped behavior. These life-long conditions have an early onset (at 2–3
years of age), high heritability (~90%) and a high male-to-female ratio (~4 to 1). ASD
affects an estimated 1.5 million Americans and apparently has a polygenic etiology (Pickles
and others 1995) though rare mutations and CNV in single genes cannot be excluded as
being responsible for a subset of cases (Morrow and others 2008; Zhao and others 2007).
The search for ASD susceptibility genes has included linkage analyses, candidate gene
studies, analysis of copy-number variations (CNVs), and genome-wide association studies
(GWAS). To date, both common and rare variants have been documented in ASD, but most
of the evidence points toward the role of rare variants. Common ASD risk alleles have been
identified from association studies of individual candidate genes with relevant
neurobehavioral phenotypes (EN2 (Benayed and others 2005; Brune and others 2007) and
OXTR (Jacob and others 2007; Liu and others; Wu and others 2005)) and of regions with
linkage/chromosomal rearrangements (CNTNAP2 (Arking and others 2008)). Recently, new
candidate locations have been identified in large-scale GWAS (Wang and others 2009a;
Weiss and others 2009; Weiss and others 2008). Searches for rare mutations and CNV point
to multiple contributing loci with very few recurrent variations. They are found in genes
responsible for synaptic connectivity, such as NRXN1 (Feng and others 2006; Szatmari and
others 2007), SHANK3 (Durand and others 2007; Moessner and others 2007), SHANK2
(Berkel and others 2010), X-linked synaptic genes (Jamain and others 2003; Lawson-Yuen
and others 2008; Piton and others 2010), melatonin-related genes (Jonsson and others 2010)
and genes involved in GTPase/Ras signaling pathways (Pinto and others 2010). The
identified rare variants are either inherited with incomplete penetrance or occur de novo, and
result in a broad spectrum of phenotypes including intellectual disability and various mental
illnesses.
Linkage to chromosome 7q is among the most robust genetic findings in autism (Alarcon
and others 2002; Ashley-Koch and others 1999; Hutcheson and others 2003; IMGSAC
1998; IMGSAC 2001; Lamb and others 2005; Schellenberg and others 2006). This region
has had at least nominally significant scores in every linkage scan with a sample size of >50
affected sibling pairs (Cook 2001). Meta-analyses confirmed the 7q linkage and refined a
genome-wide significant linkage to 7q22–32 under strict diagnosis of autism (Badner and
Gershon 2002; Trikalinos and others 2006). We and others (Lamb and others 2005;
Schellenberg and others 2006) obtained strong linkage signals at the identical location on
7q32 in non-overlapping samples. The ~20 cM common linkage peak area corresponds to 17
Mb of physical distance (242 genes; 535 transcripts).
Several linkage studies have detected parent-of-origin effects at 7q32, which corresponds to
the D7S530–D7S640 interval (Ashley-Koch and others 1999; Lamb and others 2005), these
findings suggest the involvement of an imprinted gene(s). A known cluster of imprinted
genes at this location spans ~380 kb and encompasses at least 12 annotated genes/antisense
transcripts (Supplement Table I). Among these, MEST, a paternally expressed gene, is of
particular interest because of its documented role in the regulation of mammalian behavior
(Lefebvre and others 1998). The gene is highly expressed in multiple areas of the developing
brain. In addition, miR-335 in the second MEST intron represents a regulatory element that
acts in early development on a network of neural targets and is vulnerable to environmental
exposure (Sathyan and others 2007). In this study, we addressed the presence of common
variants in the imprinted interval at 7q32 by family-based association testing, and we
searched for rare deleterious mutations in the coding sequence of MEST and nearby genes
by exon re-sequencing of subjects with autism from multiplex families positive for 7q32
linkage.
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Families with ASD (1640 individuals from 348 multiplex families with 2 or more affected
children) were recruited for studies investigating the genetics of autism at the University of
Washington. The set comprised 220 families analyzed in a previous linkage study
(Schellenberg and others 2006) and an additional 128 families acquired more recently.
Individuals were assessed using the Autism Diagnostic Interview-Revised (Lord and others
1994), the Autism Diagnostic Observation Schedule (Lord and others 2000), Diagnostic and
Statistical Manual of Mental Disorders (DSM IV) (Association 1994), and a medical history
review, as previously described (Schellenberg and others 2006). Strict criteria for Autism
were met by 83% of affected children. All subjects with ASD were screened for the absence
of Fragile × and for major chromosomal rearrangements. Using available information on
220 ASD families obtained in the whole genome linkage scan (Schellenberg and others
2006), 71 multiplex families with high scores (Z≥1) at 3 markers (D7S458, D7S530,
D7S640) within 7q32 linkage peak were selected for association analysis. For the
resequencing, 94 unrelated subjects with ASD (one per family) were used of which 47 were
from families with high linkage scores (Z≥1) and 47 were from families with non-negative
Z-scores (0<Z<1). For case-control association analysis of candidate variants, 348 unrelated
subjects with ASD (one per family) were selected. For the analysis of variant transmission in
families, all available members of 348 ASD families were genotyped.
We used two control groups which differed by sampling strategy: (1) volunteers from the
University of Washington and Seattle Community Colleges (n = 170, no health
information); (2) non-affected parents of dyslexic children (n =500). Only the second control
group is known to contain no subjects with ASD. Ethnic structure of the ASD and control
samples is provided in the Supplement Table II.
Resequencing of gene candidates
Exons and splice junctions of MEST, COPG2 and TSGA14 as well as the MEST intronic
region harboring miR-335 were sequenced in both directions using fluorescent dye
terminators (BigDye® Terminator v3.1 Cycle Sequencing Kit, Applied Biosystems, Foster
City, CA, USA) and an ABI Prism 3100 Genetic Analyzer (Applied Biosystems). Primers
were selected using Primer3 software (Whitehead Institute, Cambridge, MA, USA).
Variants were identified by sequence alignment using SEQUENCHER software (Gene
Codes Corp, Ann Arbor, MI, USA).
SNP selection and genotyping assays
SNPs with a minor allele frequency over 0.2 in the Caucasian population were selected. One
tag SNP was used per haploblock, the additional non-tag SNPs were included to allow for
denser coverage of the region. SNPs were genotyped using TaqMan SNP genotyping assays
(Applied Biosystems) and a 7900 Real-Time PCR System (Applied Biosystems).
Genotyping was performed in 384-well plates with 5 ng of genomic DNA according to the
manufacturer's protocol. Allele discrimination assays and/or custom “assay-by-design”
TaqMan SNP assays (Applied Biosystems) were used to genotype TSGA14 variants. Primer
sequences and PCR conditions are available upon request.
RNA isolation and cDNA synthesis
Postmortem brain tissues from cerebella of neurologically normal control subjects were
obtained from the Neuropathology Core Brain Bank at the University of Washington.
Average age of subjects was 70, and average postmortem interval was 4 hours. All tissue
samples were obtained following informed consent, flash frozen at time of autopsy, and
Korvatska et al. Page 3










stored at −80 C. Total RNA from cultured cells or postmortem brain tissues was extracted
using TRIzol (Invitrogen, Carlsbad, CA, USA) or RNeasy Mini Kit (Qiagen, Valencia, CA,
USA). cDNA synthesis with random primers was performed using the SuperScript III RT-
PCR kit (Invitrogen).
Ex vivo RNA splicing assay
To create a minigene construct modeling the exon-intron architecture of TSGA14 (NCBI
references: NM_018718.1; NP_061188.1), we performed 2-step cloning. First, exon 2 with
323 bp of the adjacent intron 2 sequence was amplified using primers integrating Hind III
and Not I sites:
TSGAe2_Hind III_F: ATCAAGCTTATCTGATGAAAAGGATACCACAGAA
TSGAe2_NotI_R: GATGCGGCCGCCAAAATAGAGGCTGACCTCCTG
The double-digested PCR product was subcloned into a pRc/RSV vector (Invitrogen).
Second, the 5.1 kb exon 3 – exon 4 region, which included 332 bp of adjacent intron 2




c.192+5G>A mutation was introduced by site-directed mutagenesis using QuikChange XL
site directed mutagenesis kit (Stratagene, La Jolla, CA, USA). Two independent clones with
the c.192+5G>A mutation were used in the splicing assay.
Human embryonic kidney (HEK) 293T and rat pheochromocytoma (PC12) cell lines were
maintained in DMEM medium supplemented with antibiotics (100 IU/ml penicillin, 100 μg/
ml streptomycin) and 10% fetal calf serum (HEK 293T) or 5% fetal calf serum and 10%
horse serum (PC12). Cells were seeded in triplicates in 35-mm dishes, grown to 50–70%
confluence, and transfected with 2 μg of minigene constructs using Gene Porter (Genlantis,
San Diego, CA, USA) or LipofectAMINE 2000 (Invitrogen) according to the manufacturer's
protocol. Transfection efficiency was controlled by measuring the expression of 2 μg of
pEGFP. Cells were harvested 16–20 h later, and total RNA was isolated. RT-PCR was
performed using human-specific primers positioned in TSGA14 exon 2 (5'-
CAGAACCCAAGATACCAGCA-3') and exon 4 (5'-ATCAGCTGGGCAAAAGTTGT-3').
PCR products were analyzed on 2% agarose gels, quantified and sequenced.
Transmission Disequilibrium Testing
To test for differential transmission of alleles, the FBAT program (v 1.7.1) was used (Laird
and others 2000; Rabinowitz and Laird 2000). We evaluated the default additive model,
which has reasonable power even when the underlying model is not additive and the “-e”
empirical option which tests for association in the presence of linkage (Lake and others
2000).
Bioinformatic prediction of variant pathogenicity
The effect of identified variants on RNA splicing and protein structure or function was
assessed using web-based prediction tools. Each variant was assessed by at least two
predictions using independent algorithms. NetGene2 (http://www.cbs.dtu.dk/services/
NetGene2/) (Brunak and others 1991), NNSplice (http://www.fruitfly.org/seq_tools/
splice.html) (Reese and others 1997) and HSF (http://www.umd.be/HSF/) (Desmet and
others 2009) were used to evaluate a variant's effect on splice sites. To estimate the effect of
non-synonymous coding variants, we used Pmut (http://mmb2.pcb.ub.es:8080/PMut/)
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(Ferrer-Costa and others 2005), PolyPhen (http://genetics.bwh.harvard.edu/pph/) (Ramensky
and others 2002), nnPredict (http://www.cmpharm.ucsf.edu/~nomi/nnpredict.html) (Kneller




We assessed the presence of common risk variants in the imprinted region at 7q32 by
performing family-based association analysis on a subset of 71 ASD families with the
strongest linkage scores at 7q32 interval (see Materials and Methods). We focused on the
~220 kb region that is flanked by two recombination hotspots and contains TSGA14, MEST,
COPG2, TSGA13, and KLF14 genes (Fig. 1). Fourteen SNPs were genotyped: 12 SNPs
representing 3 haploblocks within the region (tag SNPs are rs12706933, rs1421140 and
rs4067228) and 2 SNPs located outside (rs6467308 and rs290805 are tag SNPs for TSGA14
and KLF14 genic regions, respectively). While rs290805 is in a strong LD with rs4067228
and rs4067229 from the haploblock III, rs6467308 is not in LD with either haploblock
(Supplement Table III). Hence, the 14 SNPs represent an effective number of 4 independent
markers. Nominal association signals were observed in SNPs from two haploblocks: a small
9.3-kb block at the 5' end of TSGA14 (haploblock I) and a large 110-kb block that includes
all of MEST and COPG2 and part of TSGA13 (haploblock II, Table I A). Upon confining
analysis to strict diagnosis of autism, only rs2287371 signal from haploblock I was
statistically significant. This signal remained significant upon analysis of Caucasians only
(Table I B). There was no evidence of allelic fixation between haploblocks I and II in
affected individuals, which suggests the presence of different founders in our linkage-
positive ASD families (as tested by Hbat for all ethnicities, and for Caucasians only, data not
shown). We then genotyped one SNP from haploblocks I and II each in the entire set of 348
multiplex families with ASD. Both SNPs showed trend of association (Table I), but did not
reach significance after correction for multiple testing.
Mutation search in the candidate genes
With the exception of TSGA13, the protein-coding genes and microRNA residing in the
nominally associated region are expressed in the developing brain and/or have documented
roles in CNS development (Supplement Table I). For each candidate gene, we sequenced the
coding regions with adjacent splice sites in a discovery cohort of 94 unrelated subjects with
ASD (see Materials and Methods).
The translated part of MEST contained only one synonymous SNP, rs61735155 (no co-
transmission with disease, Supplement Table IV). We also examined intronic sequence
variations surrounding miR-335. A known polymorphism situated 20 nt 3' of miR-335
(rs41272366) co-segregated with the strict diagnosis of autism in 7 of 8 families in our
discovery cohort, but its frequency did not significantly differ between patient and control
groups (8/94 patients with ASD versus 5/95 controls; Fisher's exact two tailed p = 0.40).
Also, the rs41272366 minor allele was not associated with disease status in the whole ASD
family sample (data not shown). In COPG2 we found two synonymous changes, one non-
synonymous SNP and a 15 nt indel, which either were neutral and/or did not co-segregate
with disease.
In TSGA14, we identified three variants that are not listed in SNP databases and that
affected either mRNA splicing or conserved protein residues. All variants were all inherited
from unaffected fathers and co-segregated with affected status in children (Fig. 2 A–D). The
c.192+5G>A is predicted to abolish (NetGene2) or significantly weaken (NNSplice, SSF)
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the donor splice site. Two identified non-synonymous variants, P206A and C240G, are
located in exons 8 and 9 which constitute a conserved Rhodanese Homology Domain
(RHOD; NCBI ID: cd00158) of the TSGA14 protein. Pro-206 and Cys-240 are conserved
across multiple species (Supplement Fig. 1). C240G has immediate pathogenic effect on the
protein structure according to both Pmut and PolyPhen. P206A, which was found in two
unrelated families, is classified as “probably damaging” by PolyPhen, “neutral” by Pmut,
and likely to spread to the alpha-helical domain by nnPredict.
Distribution of the TSGA14 variants in the entire ASD sample and control groups
We followed up on the detection of P206A, C240G and c.192+5G>A in the discovery
cohort by genotyping our entire ASD sample and controls. 348 individuals with autism (1
subject from each family) were compared to 670 unrelated controls (Table II). When
considered together, the TSGA14 variants were enriched in a linkage-positive fraction of
ASD (4/94 versus 2/670 controls; Fisher's exact two-tailed P = 0.003), but when considered
individually, they did not reach significance. Likewise, cumulative TSGA14 variants were
enriched in total ASD cases (6/348 ASD versus 2/670 controls; Fisher's exact two tailed p =
0.022 for all ethnicities, and 5/260 ASD versus 1/624 controls; Fisher's exact two tailed p =
0.010 for Caucasians only).
To trace transmission of TSGA14 variants within families we then genotyped all available
members of the 348 ASD families (Fig. 2). Two variants, c.192+5G>A and C240G, were
found only in ASD families positive for linkage at 7q32, and within these families these
variants co-segregated with the autism phenotype in the children. P206A was present in five
ASD families: two positive for linkage, one with zero scores and two with unknown linkage
status. P206A of paternal origin was always co-transmitted with disease whereas maternal
P206A behaved as a neutral variant.
Analysis of the TSGA14 allele-specific expression
Even though the TSGA14 is reported to have bi-allelic expression in the brain and other
tissues, the proximity of imprinted genes could bias the expression in favor of one of the
alleles (Hogart and others 2007). In such a case, underexpression of the maternal allele may
increase the penetrance of otherwise recessive or hypomorphic variants in the paternal allele.
To test this, we designed an allele specific expression (ASE) assay as previously described.
(He and others 2005) (see Supplement Methods). Analysis of lymphoblastoid cell lines from
an ASD family (Fig. 2C) in which P206A was transmitted from the father revealed that
allelic differences in TSGA14 expression were not parent-of-origin specific (data not
shown).
Functional analysis of the TSGA14 c.192+5G>A variant
We sought to confirm the occurrence and type of abnormally spliced TSGA14 transcripts
bearing the c.192+5G>A variant by a cell-based splicing assay. TSGA14 splice forms
include the ubiquitous long (L) form, which encodes a centrosome-binding protein, has 11
exons, and is abundant in the brain, and the short (S) form, which encodes a testis-specific
peptide (Fig. 3A). Because the identified TSGA14 variants would only affect the L form we
omitted from the minigene construct sequences instructing S form splicing. Minigene
constructs carrying either G or A at position +5 of intron 3, were transiently transfected into
rat PC12 and human HEK-293T cells. Bands corresponding to endogenous TSGA14
transcripts in brain tissues and non-transfected human cells were observed in human as well
as in rat cell lines transfected with the wild-type minigene (Fig. 3B). Aberrant transcripts
were detected only in the cells transfected with TSGA14 c.192+5G>A mutant construct. In
both cell lines transfected with the mutant constructs aberrant transcripts constituted 58% of
total expressed TSGA14. Sequencing of these RT-PCR products demonstrated the
Korvatska et al. Page 6










production of a normally spliced allele and an erroneously spliced mRNA in which the
entire exon 3 was skipped. Thus, upon cell transfection, the c.192+5G>A variant produces a
protein lacking 16 amino acids of its internal sequence and with an additional G33D
substitution (Fig. 3C).
DISCUSSION
We hypothesized that both common and rare risk variants contribute to the ASD linkage
signal at 7q32, and that they could be identified via combination of association analysis and
mutation screening. Following the reported parent-of-origin biases at 7q32 we focused on
the cluster of imprinted genes in the D7S530- D7S640 interval. Less than 2% of human
genes are imprinted, yet they are heavily associated with neurodevelopmental pathology
(Horsthemke and Buiting 2008; Keverne and Curley 2008). We analyzed the 220 kb region
comprising imprinted MEST, COPG2, and KLF14 for association with ASD and detected
nominal positive signals with two haploblocks. Only rs2287371 residing in the 5' non-
translated region of TSGA14 passed a conservative Bonferroni correction for multiple
testing (4 markers in 4 datasets) in 7q32-linked ASD families. Given that the trend of
association in the whole sample is apparently driven by linkage-positive families, a common
susceptibility variant(s) in this region seem unlikely. The observed association may be
explained by the presence of less common or even rare causative variants which may create
“synthetic associations” by occurring, stochastically, more often in association with one of
the alleles at the common site versus the other allele (Dickson and others 2010). It is also
plausible that low risk common variants cannot be detected in this study because of
insufficient power of analysis (see Supplement Table V).
Candidate gene resequencing in linkage-positive ASD families revealed three putatively
pathogenic mutations that affected mRNA splicing and conserved amino acids in the
TSGA14 protein. P206A and C240G occur within a conserved Rhodanese domain and
hence may confer similar defects to TSGA14 structure/function. A low allele frequency of
an amino acid variant can, by itself, serve as a predictor of its functional significance
(Kryukov and others 2007). c.192+5G>A has a disruptive effect on the donor splicing site in
intron 3 confirmed by an ex vivo splicing assay. This mutation favors skipping of the entire
exon 3 in both human and rat cell lines resulting in a protein with 16 missing amino acids of
internal sequence and an additional G33D change that may confer a dominant negative
phenotype. The effect observed in cell lines may differ from brain-specific regulation;
however, exon 3 is a constitutive one, as defined by 363 GenBank accessions from 341
cDNA clones, including 59 from brain (AceView).
Cumulative frequency of TSGA14 variants in 7q32 positive ASD families significantly
exceeded their frequency in the general population, although much larger case-control
samples would be required to test each variant individually. For instance, when TSGA14
variants are counted cumulatively, the present study has a statistical power of 81% for
Caucasians only, and of 74% for all ethnicities. Individual testing of the most abundant
P206A variant at 80% power requires a minimum population size of 820 for both case and
control groups. Accordingly, a minimum of 6820 cases/controls is required to test less
frequent C240G and c.192+5g>A variants (assuming their frequency in a general population
is 1 per 1000).
Interestingly, all three variants in the 7q32-linkage positive families were transmitted
paternally. Transmission of P206A in the entire sample of ASD pedigrees may be consistent
with origin-dependent penetrance, i.e., being benign or hypomorphic on the maternal allele,
and being deleterious on the paternal allele. Such an effect could be due to differential
expression of TSGA14 alleles or to a cis-interaction with another risk factor on the same
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allele (e.g., common variant in the regulatory element). A neighborhood effect on non-
imprinted genes was observed for GABAA receptor genes located in the imprinted region at
15q11-13. Normally, these genes are biallelically expressed in the brain, but become subject
to epigenetic dysregulation in ASD brains (Hogart and others 2007). Origin-specific
expression bias was not found in lymphoblast cell lines of an ASD family carrying P206A in
TSGA14, but we cannot rule out the possibility that origin-guided regulation of this gene
occurs in the developing brain.
The TSGA14 mutations occur in the L isoform that encodes a centrosomal and microtubule-
binding protein conserved in vertebrates (Andersen and others 2003; Gache and others
2010). Structural and functional integrity of the centrosome is critical for mammalian
neurogenesis (Higginbotham and Gleeson 2007). In early neurodevelopment, asymmetric
division of radial glia progenitors accounts for nearly all neurogenesis in the developing
mammalian neocortex (Noctor and others 2004), and it is guided by asymmetry of
centrosome partition (Wang and others 2009b). Mutations in a set of centrosomal proteins
are responsible for microcephalies (Supplement Table VI), which are thought to result from
depletion of progenitors essential for brain growth (Fish and others 2006; Griffith and others
2008; Rauch and others 2008).
Directed migrations of neurons along glial fibers are essential for the development of the
laminar architecture of cortical regions of the mammalian brain and ultimately patterning of
synaptic connectivity (Hatten 2002). In the migrating neuron, the centrosome is positioned
ahead of the nucleus and guides the direction of migration. Mutations in another set of
centrosomal and microtubule-associated proteins (Supplement Table VI), specifically affect
nucleus–centrosome connection during neuronal migration (Kerjan and Gleeson 2007). This
is exemplified in lissencephaly (literally “smooth brain”), in which the brains lack cortical
furrowing.
Recent structural analyses (Andersen and others 2003) revealed that 75% of centrosomal
proteins contain coiled-coil regions and only a few had any other motifs or domains. This
raises the intriguing question of how these coiled-coil proteins cooperate to form a
pericentriolar matrix. Secondary structure prediction (Supplement Fig. 2) indicates a
significant decrease in apha-superhelix formation in the TSGA14 variant with deleted exon
3 suggesting altered folding and/or protein-protein interactions. Because TSGA14 protein is
found in a salt-soluble fraction (Andersen and others 2003), the impaired coiled-domain
formation of the mutant with deleted exon 3 may reduce TSGA14's loose association to the
centrosomal scaffold.
In conclusion, we report an initial analysis of common and rare genetic variation in the
imprinted region at 7q32 in families with ASD. Several rare substitutions of interest were
identified in TSGA14, all inherited from unaffected parents. This is an expected finding in
multiplex ASD families, in which risk alleles are likely to be inherited rather than occurring
de novo. The variants identified in this study may represent functional risk factors in autism
because (1) they are enriched in subjects with ASD; (2) they affect sequences conserved in
multiple species; (3) changes in the protein are suggestive of malfunction in a dominant
negative fashion; (4) amino acid substitutions located in a RHOD domain indicate a possible
mutation hot spot; (5) the centrosomal and microtubule-binding function of TSGA14 makes
it a plausible ASD candidate gene.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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LD structure and genes in the 220 kb region at 7q32. LD blocks are indicated by black
boxes. Triangles mark recombination hotspots. Long ticks mark approximate locations of 14
SNP from Table I on the physical map (not in scale). SNPs selected for genotyping of the
entire set of ASD families are marked by stars. Grey shaded boxes denote protein-coding
genes. miR-335 is marked by a short tick. Gene orientation is shown by arrowheads.
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Transmission of TSGA14 variants in families with ASD. (A–D) Families with positive
linkage scores, (E) zero linkage scores, (F–G) unknown linkage status. In (B) family, mother
is Caucasian and father has more than 2 races, in all other families both parents are
Caucasians. Circles indicates females, squares indicates males. White filling indicates
unaffected, black filling indicates a diagnosis of autism, gray filling indicates a diagnosis of
pervasive developmental disorder, and hatched filling indicates a learning disability.
Corresponding TSGA14 variants are shown in parentheses.
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Abnormal TSGA14 splicing detected by ex vivo splicing assay. (A) Minigene construct.
Scheme of the human TSGA14 genomic locus with the S isoform (SwissProt ID
Q9BYV8-4), the L isoform (SwissProt IDr Q9BYV8-1), and a part of the TSGA14 gene
cloned into expression vector pRcRSV. (B) RT-PCR products of spliced TSGA14
transcripts. Neg - untransfected cells, Wt - cells transfected with a minigene construct
carrying wild-type allele (c.192+5G), Mut - cells transfected with a minigene construct
carrying c.192+5A mutation, brain - RT-PCR product from control human brain mRNA,
NTC - no template control PCR. (C) Exon 3 skipping, which results in G33D change and the
deletion of 16 amino acids.
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Table II
Distribution of TSGA14 variants in cases and controls. (A) All ethnicities are analyzed. (B) Caucasians only
are analyzed. 348 unrelated affected subjects from 348 multiplex ASD families and 670 control subjects from
2 control groups (see Materials and Methods for the description of controls).
A
Exon Nt change Aa change Discovery cohort (N=94) ASD sample (N=348) Control 1 (N=170) Control 2 (N=500) Total control (N=670)
e3 +
5 nt c.192+5 G> A na 1 1 0 0 0
e9 c.766T>G C240G 1 1 0 0 0
e8 C.664C> G P206A 2 4 1 1 2
Cumulative TSGA14 variants 4 6 1 1 2
B
Exon Nt change Aa change ASD sample (N=260) Control 1 (N=134) Control 2(N=490) Total control (N=624)
e3 + 5 nt c.192+5 G> A na 1 0 0 0
e9 c.766T>G C240G 0 0 0 0
e8 C.664C> G P206A 4 0 1 1
Cumulative TSGA14 variants 5 0 1 1
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